Sekeres, M. A., Garcia-Manero, G., Grinblatt, D. L., Komrokji, R. S., Savona, M. R., Erba, H. P., … Scott, B. L. (2022). Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes. In Blood (Vol. 140, pp. 9818–9820). American Society of Hematology. https://doi.org/10.1182/blood-2022-158075

Sekeres, Mikkael A., Guillermo Garcia-Manero, David L. Grinblatt, Rami S. Komrokji, Michael R. Savona, Harry P. Erba, Gail J. Roboz, et al. “Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes.” In Blood, 140:9818–20. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-158075.

Sekeres MA, Garcia-Manero G, Grinblatt DL, Komrokji RS, Savona MR, Erba HP, et al. Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes. In: Blood. American Society of Hematology; 2022. p. 9818–20.

Sekeres, Mikkael A., et al. “Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 9818–20. Crossref, doi:10.1182/blood-2022-158075.

Sekeres MA, Garcia-Manero G, Grinblatt DL, Komrokji RS, Savona MR, Erba HP, Roboz GJ, DeGutis IS, Kiselev P, Yu E, Makinde AY, McBride A, Scott BL. Impact of Transfusions and Treatment Choice on Time Spent in Healthcare Facilities for Patients with Myelodysplastic Syndromes. Blood. American Society of Hematology; 2022. p. 9818–9820.